Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes

Journal of Neurophysiology

Volumn 97, Issue 1, 2007, Pages 102-109

  Zhang, Hong Mei ^a   Chen, Shao Rui ^a   Pan, Hui Lin ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; GLUTAMIC ACID; HIMBACINE; MUSCARINIC RECEPTOR; OTENZEPAD; OXOTREMORINE M; PERTUSSIS TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; INTERNEURON; NONHUMAN; PRIMARY AFFERENT DEPOLARIZATION; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL GANGLION;

AFFERENT PATHWAYS; ANIMALS; DRUG INTERACTIONS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; INTERNEURONS; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEURAL INHIBITION; ORGAN CULTURE TECHNIQUES; POSTERIOR HORN CELLS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; SPINAL CORD; SPINAL NERVE ROOTS; SYNAPTIC TRANSMISSION;

EID: 33846464673     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00586.2006     Document Type: Article

References (41)

1. Bonner TI. The molecular basis of muscarinic receptor diversity. Trends Neurosci 12: 148-151, 1989.
2. Caulfield MP. Muscarinic receptors - characterization, coupling and function. Pharmacol Ther 58: 319-379, 1993.
3. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50: 279-290, 1998.
4. Chen S-R, Pan H-L. Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats. J Pharmacol Exp Ther 307: 676-681, 2003.
5. Chen S-R, Pan H-L. Activation of muscarinic receptors inhibits spinal dorsal horn projection neurons: role of GABAB receptors. Neuroscience 125: 141-148, 2004.
6. Chen S-R, Wess J, Pan H-L. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice. J Pharmacol Exp Ther 313: 765-770, 2005.
7. Coelho JE, de Mendonca A, Ribeiro JA. Presynaptic inhibitory receptors mediate the depression of synaptic transmission upon hypoxia in rat hippocampal slices. Brain Res 869: 158-165, 2000.
8. Doller D, Chackalamannil S, Czarniecki M, McQuade R, Ruperto V. Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists. Bioorg Med Chem Lett 9: 901-906, 1999.
9. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256: 727-733, 1991.
10. Douglas CL, Baghdoyan HA, Lydic R. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse. J Pharmacol Exp Ther 299: 960-966, 2001.
11. Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, Wess J. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62: 1084-1093, 2002.
12. Ehlert FJ. The interaction of 4-DAMP mustard with subtypes of the muscarinic receptor. Life Sci 58: 1971-1978, 1996.
13. Ellis JL, Harman D, Gonzalez J, Spera ML, Liu R, Shen TY, Wypij DM, Zuo F. Development of muscarinic analgesics derived from epibatidine: role of the M4 receptor subtype. J Pharmacol Exp Ther 288: 1143-1150, 1999.
14. Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9: 619-625, 1995.
15. Fields TA, Casey PJ. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321: 561-571, 1997.
16. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96: 1692-1697, 1999.
17. Grillner P, Bonci A, Svensson TH, Bernardi G, Mercuri NB. Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon. Neuroscience 91: 557-565, 1999.
18. Hoglund AU, Baghdoyan HA. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord. J Pharmacol Exp Ther 281: 470-477, 1997.
19. Hood DD, Mallak KA, James RL, Tuttle R, Eisenach JC. Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J Pharmacol Exp Ther 282: 86-92, 1997.
20. Iwamoto ET, Marion L. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J Pharmacol Exp Ther 266: 329-338, 1993.
21. Jolkkonen M, van Giersbergen PL, Hellman U, Wernstedt C, Karlsson E. A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett 352: 91-94, 1994.
22. Li D-P, Chen S-R, Pan Y-Z, Levey AI, Pan H-L. Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 543: 807-818, 2002.
23. Liang JS, Carsi-Gabrenas J, Krajewski JL, McCafferty JM, Purkerson SL, Santiago MP, Strauss WL, Valentine HH, Potter LT. Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon 34: 1257-1267, 1996.
24. Miller JH, Aagaard PJ, Gibson VA, McKinney M. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors. J Pharmacol Exp Ther 263: 663-667, 1992.
25. Naguib M, Yaksh TL. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology 80: 1338-1348, 1994.
26. Naguib M, Yaksh TL. Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 85: 847-853, 1997.
27. 2-adrenergic receptors. J Neurophysiol 87: 1938-1947, 2002.
28. Scatton B, Dubois A, Javoy-Agid F, Camus A. Autoradiographic localization of muscarinic cholinergic receptors at various segmental levels of the human spinal cord. Neurosci Lett 49: 239-245, 1984.
29. 3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro. J Physiol 525: 331-341, 2000.
30. Shi H, Yang B, Xu D, Wang H, Wang Z. Electrophysiological characterization of cardiac muscarinic acetylcholine receptors: different subtypes mediate different potassium currents. Cell Physiol Biochem 13: 59-74, 2003.
31. Villiger JW, Faull RL. Muscarinic cholinergic receptors in the human spinal cord: differential localization of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding sites. Brain Res 345: 196-199, 1985.
32. Wang X-L, Zhang H-M, Chen S-R, Li D-P, Pan H-L. Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats. J Physiol 571: 403-413, 2006.
33. Watson N, Daniels DV, Ford AP, Eglen RM, Hegde SS. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells. Br J Pharmacol 127: 590-596, 1999.
34. 5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J Neurochem 63: 815-821, 1994.
35. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10: 69-99, 1996.
36. 3H]pirenzepine. Eur J Pharmacol 91: 147-149, 1983.
37. Yigit M, Keipert C, Backus KH. Muscarinic acetylcholine receptors potentiate the GABAergic transmission in the developing rat inferior colliculus. Neuropharmacology 45: 504-513, 2003.
38. Yoshimura M, Jessell T. Amino acid-mediated EPSPs at primary afferent synapses with substantia gelatinosa neurones in the rat spinal cord. J Physiol 430: 315-335, 1990.
39. 2 receptor in the rat spinal cord. Neurosci Lett 229: 81-84, 1997.
40. Zhang H-M, Chen S-R, Matsui M, Gautam D, Wess J, Pan H-L. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice. Mol Pharmacol 69: 1048-1055, 2006.
41. Zhang H-M, Li D-P, Chen S-R, Pan H-L. M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons. J Pharmacol Exp Ther 313: 697-704, 2005.